Bioarctic Ab Stock Performance
| BRCTF Stock | 34.74 0.12 0.35% |
On a scale of 0 to 100, BioArctic holds a performance score of 5. The firm shows a Beta (market volatility) of 0.48, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BioArctic's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioArctic is expected to be smaller as well. Please check BioArctic's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to make a quick decision on whether BioArctic's price patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in BioArctic AB are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioArctic reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 999.9 M | |
| Total Cashflows From Investing Activities | -4.4 M |
BioArctic |
BioArctic Relative Risk vs. Return Landscape
If you would invest 3,138 in BioArctic AB on September 28, 2025 and sell it today you would earn a total of 336.00 from holding BioArctic AB or generate 10.71% return on investment over 90 days. BioArctic AB is currently producing 0.2026% returns and takes up 2.9284% volatility of returns over 90 trading days. Put another way, 26% of traded pink sheets are less volatile than BioArctic, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
BioArctic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioArctic's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as BioArctic AB, and traders can use it to determine the average amount a BioArctic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0692
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BRCTF | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average BioArctic is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioArctic by adding it to a well-diversified portfolio.
BioArctic Fundamentals Growth
BioArctic Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of BioArctic, and BioArctic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioArctic Pink Sheet performance.
| Return On Equity | -0.0142 | |||
| Return On Asset | -0.0055 | |||
| Profit Margin | (0.05) % | |||
| Current Valuation | 2.53 B | |||
| Shares Outstanding | 73.73 M | |||
| Price To Book | 28.65 X | |||
| Price To Sales | 104.82 X | |||
| Revenue | 23.15 M | |||
| EBITDA | (126.57 M) | |||
| Cash Flow From Operations | (140.46 M) | |||
| Earnings Per Share | 0.03 X | |||
| Total Asset | 897.73 M | |||
About BioArctic Performance
By analyzing BioArctic's fundamental ratios, stakeholders can gain valuable insights into BioArctic's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioArctic has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioArctic has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about BioArctic AB performance evaluation
Checking the ongoing alerts about BioArctic for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for BioArctic AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| BioArctic AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 23.15 M. Net Loss for the year was (119.79 M) with profit before overhead, payroll, taxes, and interest of 155.53 M. | |
| BioArctic generates negative cash flow from operations | |
| About 48.0% of the company shares are held by company insiders |
- Analyzing BioArctic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioArctic's stock is overvalued or undervalued compared to its peers.
- Examining BioArctic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioArctic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioArctic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioArctic's pink sheet. These opinions can provide insight into BioArctic's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BioArctic Pink Sheet analysis
When running BioArctic's price analysis, check to measure BioArctic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioArctic is operating at the current time. Most of BioArctic's value examination focuses on studying past and present price action to predict the probability of BioArctic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioArctic's price. Additionally, you may evaluate how the addition of BioArctic to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |